Last reviewed · How we verify

NCT01158066

Association Between NAFLD and Coronary Artery Calcification

Status unknown NA Last updated 5 April 2011
What this trial tests

NA trial testing CT Cardiac in Coronary Artery Calcification in 120 participants. Status unknown.

Timeline
1 August 2011
Primary endpoint
1 January 2012
1 March 2012

Quick facts

Lead sponsorZiv Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment120
Start date1 August 2011
Primary completion1 January 2012
Estimated completion1 March 2012
Sites1 location across Israel

Drugs / interventions tested

Conditions studied

Sponsor

Ziv Hospital

Who can join

Adults 45 to 75, any sex, with Coronary Artery Calcification. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Sponsor's own description

Coronary artery disease are 8 times more prevalent in patients with NAFLD then the general population and are being considered the most common cause of death. Cardiac CT is a reliable non invasive method in demonstrating Coronary Plaques. However the association between coronary artery calcium score (CAC) and NAFLD remains controversial

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Coronary Artery Calcification

Currently open trials in the same condition.

Other Ziv Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01158066.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing